(VBK) VERBIO Vereinigte BioEnergie - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: XETRA (Germany) | Market Cap: 2.770m EUR | Total Return: 366.1% in 12m

Biofuels, Biogas, Chemicals, Feed
Total Rating 55
Safety 63
Buy Signal -0.21
Specialty Chemicals
Industry Rotation: +7.1
Market Cap: 3.19B
Avg Turnover: 11.9M EUR
ATR: 6.43%
Peers RS (IBD): 98.6
Risk 5d forecast
Volatility81.3%
Rel. Tail Risk-11.2%
Reward TTM
Sharpe Ratio2.65
Alpha358.42
Character TTM
Beta0.301
Beta Downside0.481
Drawdowns 3y
Max DD82.68%
CAGR/Max DD0.01
EPS (Earnings per Share) EPS (Earnings per Share) of VBK over the last years for every Quarter: "2021-03": 0.28, "2021-06": 0.5, "2021-09": 0.36, "2021-12": 1.54, "2022-03": 1.26, "2022-06": 1.8114, "2022-09": 1.21, "2022-12": 0.39, "2023-03": 0.3468, "2023-06": 0.13, "2023-09": 0.34, "2023-12": 0.01, "2024-03": -0.1757, "2024-06": 0.13, "2024-09": -0.3605, "2024-12": -0.05, "2025-03": -0.22, "2025-06": -1.5284, "2025-09": -0.06, "2025-12": 0.053,
EPS CAGR: -57.04%
EPS Trend: -79.4%
Last SUE: 0.13
Qual. Beats: 0
Revenue Revenue of VBK over the last years for every Quarter: 2021-03: 237.758, 2021-06: 309.183, 2021-09: 350.428, 2021-12: 458.719, 2022-03: 428.374, 2022-06: 574.956, 2022-09: 592.165, 2022-12: 485.495, 2023-03: 443.628, 2023-06: 446.993, 2023-09: 488.135, 2023-12: 420.749, 2024-03: 409.24, 2024-06: 342.546, 2024-09: 358, 2024-12: 393.586, 2025-03: 394.874, 2025-06: 433.373, 2025-09: 438.23, 2025-12: 455.425,
Rev. CAGR: 1.65%
Rev. Trend: -52.2%
Last SUE: 1.76
Qual. Beats: 1

Warnings

High Debt while negative Cash Flow

Interest Coverage Ratio -4.8 is critical

Volatile

Tailwinds

No distinct edge detected

Description: VBK VERBIO Vereinigte BioEnergie

VERBIO SE produces and distributes biofuels and related products globally. The company operates in Biodiesel, Bioethanol/Biomethane, and Other segments.

Its product portfolio includes biodiesel, biomethane, bioethanol, and pharma-glycerine. These are derived from agricultural raw materials. Biofuel production typically involves processing biomass into liquid or gaseous fuels.

VERBIO also offers animal feeds, phytosterols, and fertilizers. The company serves diverse sectors including oil, pharmaceuticals, transport, and agriculture. The renewable energy sector is experiencing growth due to increasing demand for sustainable alternatives.

For more detailed financial and operational data, ValueRay offers in-depth company analyses.

Headlines to Watch Out For
  • Biofuel demand and pricing impact revenue
  • Regulatory changes for renewable energy affect profitability
  • Raw material costs for biodiesel and bioethanol fluctuate
  • Global energy prices influence product competitiveness
Piotroski VR‑10 (Strict) 4.0
Net Income: -112.2m TTM > 0 and > 6% of Revenue
FCF/TA: -0.05 > 0.02 and ΔFCF/TA -0.55 > 1.0
NWC/Revenue: 13.28% < 20% (prev 20.00%; Δ -6.72% < -1%)
CFO/TA 0.03 > 3% & CFO 43.3m > Net Income -112.2m
Net Debt (215.7m) to EBITDA (47.2m): 4.57 < 3
Current Ratio: 1.75 > 1.5 & < 3
Outstanding Shares: last quarter (67.6m) vs 12m ago 14.19% < -2%
Gross Margin: 6.98% > 18% (prev 0.16%; Δ 682.8% > 0.5%)
Asset Turnover: 128.8% > 50% (prev 107.5%; Δ 21.25% > 0%)
Interest Coverage Ratio: -4.79 > 6 (EBITDA TTM 47.2m / Interest Expense TTM 18.0m)
Altman Z'' 1.71
A: 0.18 (Total Current Assets 532.2m - Total Current Liabilities 303.4m) / Total Assets 1.28b
B: 0.15 (Retained Earnings 197.0m / Total Assets 1.28b)
C: -0.06 (EBIT TTM -86.4m / Avg Total Assets 1.34b)
D: 0.44 (Book Value of Equity 234.0m / Total Liabilities 533.3m)
Altman-Z'' Score: 1.71 = BBB
Beneish M -2.40
DSRI: 1.02 (Receivables 106.5m/91.5m, Revenue 1.72b/1.50b)
GMI: 2.23 (GM 6.98% / 15.55%)
AQI: 0.20 (AQ_t 0.00 / AQ_t-1 0.02)
SGI: 1.15 (Revenue 1.72b / 1.50b)
TATA: -0.12 (NI -112.2m - CFO 43.3m) / TA 1.28b)
Beneish M-Score: -2.40 (Cap -4..+1) = BBB
What is the price of VBK shares? As of April 09, 2026, the stock is trading at EUR 36.96 with a total of 635,984 shares traded.
Over the past week, the price has changed by -8.74%, over one month by +28.51%, over three months by +67.09% and over the past year by +366.08%.
Is VBK a buy, sell or hold? VERBIO Vereinigte BioEnergie has no consensus analysts rating.
What are the forecasts/targets for the VBK price?
Analysts Target Price - -
VERBIO Vereinigte BioEnergie (VBK) - Fundamental Data Overview as of 06 April 2026
Market Cap USD = 3.19b (2.77b EUR * 1.152 EUR.USD)
P/E Forward = 6.7385
P/S = 1.6019
P/B = 3.7298
P/EG = 5.8004
Revenue TTM = 1.72b EUR
EBIT TTM = -86.4m EUR
EBITDA TTM = 47.2m EUR
Long Term Debt = 173.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 94.9m EUR (from shortTermDebt, last quarter)
Debt = 287.2m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 215.7m EUR (from netDebt column, last quarter)
Enterprise Value = 2.97b EUR (2.77b + Debt 287.2m - CCE 86.0m)
Interest Coverage Ratio = -4.79 (Ebit TTM -86.4m / Interest Expense TTM 18.0m)
EV/FCF = -42.40x (Enterprise Value 2.97b / FCF TTM -70.1m)
FCF Yield = -2.36% (FCF TTM -70.1m / Enterprise Value 2.97b)
FCF Margin = -4.07% (FCF TTM -70.1m / Revenue TTM 1.72b)
Net Margin = -6.52% (Net Income TTM -112.2m / Revenue TTM 1.72b)
Gross Margin = 6.98% ((Revenue TTM 1.72b - Cost of Revenue TTM 1.60b) / Revenue TTM)
Gross Margin QoQ = 17.38% (prev 13.21%)
Tobins Q-Ratio = 2.33 (Enterprise Value 2.97b / Total Assets 1.28b)
Interest Expense / Debt = 0.80% (Interest Expense 2.30m / Debt 287.2m)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -64.8m (EBIT -86.4m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 1.75 (Total Current Assets 532.2m / Total Current Liabilities 303.4m)
Debt / Equity = 0.39 (Debt 287.2m / totalStockholderEquity, last quarter 742.8m)
Debt / EBITDA = 4.57 (Net Debt 215.7m / EBITDA 47.2m)
 Debt / FCF = -3.08 (negative FCF - burning cash) (Net Debt 215.7m / FCF TTM -70.1m)
 Total Stockholder Equity = 776.0m (last 4 quarters mean from totalStockholderEquity)
RoA = -8.39% (Net Income -112.2m / Total Assets 1.28b)
RoE = -14.46% (Net Income TTM -112.2m / Total Stockholder Equity 776.0m)
RoCE = -9.10% (EBIT -86.4m / Capital Employed (Equity 776.0m + L.T.Debt 173.4m))
 RoIC = -6.29% (negative operating profit) (NOPAT -64.8m / Invested Capital 1.03b)
 WACC = 6.44% (E(2.77b)/V(3.06b) * Re(7.04%) + D(287.2m)/V(3.06b) * Rd(0.80%) * (1-Tc(0.25)))
Discount Rate = 7.04% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: -33.33 | Cagr: -8.32%
 [DCF] Fair Price = unknown (Cash Flow -70.1m)
 EPS Correlation: -79.37 | EPS CAGR: -57.04% | SUE: 0.13 | # QB: 0
Revenue Correlation: -52.22 | Revenue CAGR: 1.65% | SUE: 1.76 | # QB: 1
EPS current Year (2026-06-30): EPS=0.54 | Chg7d=+0.184 | Chg30d=+0.250 | Revisions Net=+3 | Growth EPS=+125.0% | Growth Revenue=+16.7%
EPS next Year (2027-06-30): EPS=1.76 | Chg7d=+0.691 | Chg30d=+0.718 | Revisions Net=+3 | Growth EPS=+224.1% | Growth Revenue=+12.4%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Current Year)